Trump's Autism Warning Spurs Drop in ER Tylenol Use by Pregnant Women

Pregnant women in emergency rooms significantly reduced their use of acetaminophen — sold as Tylenol — following President Trump's September 2025 White House announcement warning that the common pain reliever could raise babies' risk of autism, according to a study published in The Lancet.

The study tracked acetaminophen use among pregnant ER patients before and after the presidential announcement. Researchers found a measurable behavioral shift in medication use tied directly to the timing of Trump's warning. Scientists who conducted the research emphasized that no proven causal link between acetaminophen use during pregnancy and autism has been established in the medical literature.

For Treasure Coast families, the findings carry practical weight. Acetaminophen is one of the few pain relievers considered generally safe during pregnancy and is widely recommended by OB-GYNs in Martin, St. Lucie and Indian River counties for fever management — a condition that, left untreated, carries its own documented risks to fetal development. Physicians caution that unmanaged high fevers during pregnancy can pose serious complications.

Medical experts expressed concern that public health messaging disconnected from the scientific consensus could lead pregnant patients to forgo treatments their doctors recommend. The Lancet study adds to a growing body of research examining how high-profile political statements shape patient behavior independently of clinical guidance. Treasure Coast residents with questions about medication use during pregnancy should consult their OB-GYN or a licensed healthcare provider rather than adjusting medication use based on public announcements alone.

This article was generated with AI assistance using publicly available information. It was reviewed and approved by a human editor before publication. TC Sentinel uses AI writing tools in accordance with FTC guidelines.